These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24213458)

  • 1. Atomoxetine-induced mydriasis in a child patient.
    Bahali K; Ipek H; Yalcin O; Orum O
    Eur Child Adolesc Psychiatry; 2014 Dec; 23(12):1231-2. PubMed ID: 24213458
    [No Abstract]   [Full Text] [Related]  

  • 2. Atomoxetine-induced mydriasis.
    Alhatem FJ; Decker DH
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):539-41. PubMed ID: 18928421
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-dependent Raynaud's phenomenon developing from use of atomoxetine in a girl.
    Gökçen C; Kutuk MO; Coşkun Ş
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):428-30. PubMed ID: 23952193
    [No Abstract]   [Full Text] [Related]  

  • 4. Atomoxetine-induced wake-time teeth clenching and sleep bruxism in a child patient.
    Bahali K; Yalcin O; Avci A
    Eur Child Adolesc Psychiatry; 2014 Dec; 23(12):1233-5. PubMed ID: 25159091
    [No Abstract]   [Full Text] [Related]  

  • 5. Suboptimal dosing of Strattera (atomoxetine) for ADHD patients.
    Clemow DB
    Postgrad Med; 2014 Sep; 126(5):196-8. PubMed ID: 25420287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.
    Adler LA; Spencer T; Brown TE; Holdnack J; Saylor K; Schuh K; Trzepacz PT; Williams DW; Kelsey D
    J Clin Psychopharmacol; 2009 Feb; 29(1):44-50. PubMed ID: 19142107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder.
    Takahashi M; Takita Y; Goto T; Ichikawa H; Saito K; Matsumoto H; Tanaka Y
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):55-63. PubMed ID: 21265936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder.
    Wietecha LA; Williams DW; Herbert M; Melmed RD; Greenbaum M; Schuh K
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):719-30. PubMed ID: 20035590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study.
    Hammerness P; Doyle R; Kotarski M; Georgiopoulos A; Joshi G; Zeitlin S; Biederman J
    Eur Child Adolesc Psychiatry; 2009 Aug; 18(8):493-8. PubMed ID: 19377865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
    Garnock-Jones KP; Keating GM
    Paediatr Drugs; 2009; 11(3):203-26. PubMed ID: 19445548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does atomoxetine increase the risk of aggression and hostility in children with attention deficit hyperactivity disorder?
    Banerjee S; Ayyash HF
    Arch Dis Child Educ Pract Ed; 2008 Aug; 93(4):131-2. PubMed ID: 18644903
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of attention deficit hyperactivity disorder with comorbid tic hyperkinesis].
    Chutko LS; Surushkina SIu; Nikishena IS; Iakovenko EA; Lapshina OV; Anisimova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):66-8. PubMed ID: 18646384
    [No Abstract]   [Full Text] [Related]  

  • 13. Open-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorder.
    Takahashi M; Goto T; Takita Y; Chung SK; Wang Y; Gau SS
    Asia Pac Psychiatry; 2014 Mar; 6(1):62-70. PubMed ID: 23857916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atomoxetine--Strattera. Oral preparation].
    Duh PD; Macken E
    J Pharm Belg; 2006; 61(4):117-20. PubMed ID: 17263193
    [No Abstract]   [Full Text] [Related]  

  • 15. Children and adolescent exposures to atomoxetine hydrochloride reported to a poison control center.
    Stojanovski SD; Robinson RF; Baker SD; Casavant MJ; Hayes JR; Nahata MC
    Clin Toxicol (Phila); 2006; 44(3):243-7. PubMed ID: 16749540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electroencephalographic study of children with attention deficit hyperactivity disorder before and after treatment with strattera].
    Nikishina IS; Chutko LS; Surushina SIu; Iakovenko EA; Kropotov IuD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):60-2. PubMed ID: 19253469
    [No Abstract]   [Full Text] [Related]  

  • 17. [My child is so restless].
    Schlamp D
    MMW Fortschr Med; 2007 Mar; 149(10):39-40. PubMed ID: 17408047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent camptocormia associated with atomoxetine in a child with attention-deficit/hyperactivity disorder.
    Bhattacharya A; Praharaj SK; Sinha VK
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):596-7. PubMed ID: 25469421
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of severe akathisia with atomoxetine.
    Baweja R; Petrovic-Dovat L
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):426-7. PubMed ID: 23952192
    [No Abstract]   [Full Text] [Related]  

  • 20. Atomoxetine-induced hypomania-like symptoms in a preadolescent patient.
    Guney E; Uneri OS
    J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):530-1. PubMed ID: 24494808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.